99m-Tc-Ethylenedicysteine-glucosamine

N/A

Report date: 2025/11/26 17:11:05

Base Information

Drug Name99m-Tc-Ethylenedicysteine-glucosamine
Drug Alias NameTechnetium-99m-labeled ethylenedicysteine-glucosamineTechnetium-99m-labeled Ethylenedicysteine-Deoxyglucose99mTc ethylenedicysteine N-acetyl glucosamineTc 99m ethylenedicysteine glucosamineTechnetium TC 99m ECDG +[12] 
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTc +[4] 
Mechanisms of ActionIonising radiation emittersSingle-photon emission-computed tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsCoronary Artery DiseaseCarcinoma, Non-Small-Cell LungLung Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesCellPoint LLCZhejiang Lianhui Pharmaceutical Technology Co Ltd
Inactive CompaniesThe University Of Chicago
Active IndicationsCoronary Artery DiseaseCarcinoma, Non-Small-Cell LungLung Neoplasms
Inactive IndicationsHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A